Histocompatibility TestingTissue DonorsBone Marrow TransplantationHistocompatibilityGraft vs Host DiseaseTransplantation, HomologousBone MarrowHLA AntigensBone Marrow CellsUnrelated DonorsTransplantation ConditioningTissue and Organ ProcurementTreatment OutcomeBone and BonesWhole-Body IrradiationBlood DonorsHematopoietic Stem Cell TransplantationGraft SurvivalLeukemiaLiving DonorsHost vs Graft ReactionHematopoietic Stem CellsRegistriesAnemia, AplasticRadiation ChimeraHematologic NeoplasmsBone Marrow DiseasesCord Blood Stem Cell TransplantationTransplantation ChimeraBone Marrow ExaminationLymphocyte DepletionLeukocyte TransfusionRecurrenceBone Marrow NeoplasmsSurvival AnalysisGraft RejectionBone RemodelingMice, Inbred C57BLT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsBone Marrow PurgingHematopoiesisTime FactorsBone DensityDisease-Free SurvivalAcute DiseaseRetrospective StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation, AutologousGraft vs Host ReactionBone ResorptionMyelodysplastic SyndromesColony-Forming Units AssayLeukemia, Myeloid, AcuteBusulfanSurvival RateHLA-A AntigensPeripheral Blood Stem Cell TransplantationCell DifferentiationAntilymphocyte SerumImmunosuppressionHematologic DiseasesCells, CulturedBone NeoplasmsVidarabineFetal BloodMyeloablative AgonistsDonor SelectionAntigens, CD34SiblingsStromal CellsBlood Component RemovalFlow CytometryBone DevelopmentRemission InductionBone DiseasesSpleenCyclophosphamideTransplantation ImmunologyLeukemia, MyeloidHLA-DP beta-ChainsGranulocytesStem Cell TransplantationGranulocyte Colony-Stimulating FactorMultiple MyelomaAllelesOsteogenesisBone RegenerationBlood Cell CountLeukocyte CountTransplantation, IsogeneicCell SeparationPancytopeniaMice, Inbred BALB CCyclosporineActuarial AnalysisPolymerase Chain ReactionFollow-Up StudiesMethotrexate